Available in July 2017


Renaissance Brussels Hotel
Rue du Parnasse 19 Brussels 1050 Belgium

Many stakeholders believe innovation only leads to generating new molecules, but innovation can also come from other areas such as focusing on improving present molecules which are no longer protected by patent.

There is significant untapped potential in Europe to optimise existing therapies and value added medicines represent an opportunity for patients, healthcare providers, payers and the industry.

Come and join us for the first Value Added Medicines Conference in Brussels to learn more and to discuss the challenges and opportunities for value added medicines in Europe.

More details by the end of June 2017.